- Home
- CITE vs FENC Comparison
CITE vs FENC Comparison
Compare CITE & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CITE
- FENC
- Stock Information
- Founded
- CITE 2021
- FENC 1996
- Country
- CITE United States
- FENC United States
- Employees
- CITE N/A
- FENC N/A
- Industry
- CITE
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CITE
- FENC Health Care
- Exchange
- CITE NYSE
- FENC Nasdaq
- Market Cap
- CITE 92.2M
- FENC 109.5M
- IPO Year
- CITE 2022
- FENC 2001
- Fundamental
- Price
- CITE $11.55
- FENC $4.72
- Analyst Decision
- CITE
- FENC Strong Buy
- Analyst Count
- CITE 0
- FENC 2
- Target Price
- CITE N/A
- FENC $14.00
- AVG Volume (30 Days)
- CITE 22.8K
- FENC 134.0K
- Earning Date
- CITE 01-01-0001
- FENC 11-07-2024
- Dividend Yield
- CITE N/A
- FENC N/A
- EPS Growth
- CITE N/A
- FENC N/A
- EPS
- CITE N/A
- FENC N/A
- Revenue
- CITE N/A
- FENC $49,348,000.00
- Revenue This Year
- CITE N/A
- FENC $116.50
- Revenue Next Year
- CITE N/A
- FENC $17.49
- P/E Ratio
- CITE N/A
- FENC N/A
- Revenue Growth
- CITE N/A
- FENC 278.09
- 52 Week Low
- CITE $10.79
- FENC $3.96
- 52 Week High
- CITE $12.25
- FENC $11.92
- Technical
- Relative Strength Index (RSI)
- CITE 65.68
- FENC 54.72
- Support Level
- CITE $11.53
- FENC $3.99
- Resistance Level
- CITE $11.57
- FENC $4.57
- Average True Range (ATR)
- CITE 0.01
- FENC 0.34
- MACD
- CITE 0.00
- FENC 0.04
- Stochastic Oscillator
- CITE 85.72
- FENC 61.79
About CITE CARTICA ACQUISITION CORP
Cartica Acquisition Corp is a blank check company.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.